Makemydaze: Thank you for the new article.
''Regarding the potential of ANAVEX 2-73, while I am no scientist leading experts are saying that Eli Lilly and Biogen may have the science all wrong and that AVXL has it correct. The drugs from Eli Lilly and Biogen are just antibodies against amyloid. In all likelihood, amyloid is not the cause of Alzheimer’s. Instead, Alzheimer’s is caused by oxidation and nitration. This is what ANAVEX 2-73 targets!! It’s a completely new approach to treating Alzheimer’s and that makes it so revolutionary. With anything this revolutionary, you will get conventional scientists coming out and bashing the new science. This is what is happening with AVXL because AVXL is disputing the conventional wisdom.
The funny thing with AVXL is that when the bears are given the facts of the science, they turn to their favorite tactic. They criticize the company because it came public via a shell. Well, when you have a drug that goes against the tide, traditional venture capitalists do not want to take this type of risk. They don’t want to go up against Eli Lilly and Biogen because they are in business with the big drug companies. The big drug companies don’t want AVXL to succeed. They want it to fail!''
The above quote from this article gets to the root of what is going on with this new scientific approach by Anavex to treat AZ. Remember, that scientists who come up with new discoveries have been persecuted throughout history. Galileo, for example, was persecuted in 1633 for publishing a treatise on his observation that the earth revolves around the sun. Revolutionary new discoveries go against established theories and beliefs. And yes, there is a huge amount of money at stake. Big pharma companies do not desire that their billion dollar monopolies on drugs that do not work to be damaged. It would be heart warming, however, for one of the big pharma companies to step up and say we put the patient first -- not our bottom line --. We are willing to take a chance to see if Anavex 2-73 works!
